Grégor Andelfinger
-
- Chemotherapy-induced cardiotoxicity and mitigation 15
- Cardiac Valve Diseases and Treatments 10
- Cardiac electrophysiology and arrhythmias 6
-
- Aortic Disease and Treatment Approaches 8
- Epidemiology top 5%
- Congenital Heart Disease Studies 23
- Molecular Biology top 5%
- Congenital heart defects research 23
- Protein Tyrosine Phosphatases 6
-
- Childhood Cancer Survivors' Quality of Life 12
- Co-authors
- D. Woodrow BensonKerry A. ShoonerLisa J. MartinLinda CripeMona NemerBrigitte LaforestAlfred L. GeorgePatrick van Vliet
- Journals
- Canadian Journal of Cardiology (11 papers)Journal of Pediatric Hematology/Oncology (3 papers)PLoS Genetics (3 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Grégor Andelfinger
93 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 120
- Cardiology and Cardiovascular Medicine 1.4k
- Pulmonary and Respiratory Medicine 901
- Epidemiology 880
- Molecular Biology 1.5k
- Pediatrics, Perinatology and Child Health 319
Countries citing papers authored by Grégor Andelfinger
This map shows the geographic impact of Grégor Andelfinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grégor Andelfinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grégor Andelfinger more than expected).
Fields of papers citing papers by Grégor Andelfinger
This network shows the impact of papers produced by Grégor Andelfinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grégor Andelfinger. The network helps show where Grégor Andelfinger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Grégor Andelfinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 44 | |
| 7 | 2023 | 13 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 5 | |
| 11 | 2020 | 7 | |
| 12 | 2019 | 23 | |
| 13 | 2015 | 83 | |
| 14 | Nuclear Localization of Protease-Activated Receptor 2 Dictates Angiogenesis | 2010 | 1 |
| 15 | 2004 | 1 | |
| 16 | 2004 | 408 | |
| 17 | 2003 | 4 | |
| 18 | 2003 | 52 | |
| 19 | 2002 | 166 | |
| 20 | 1995 | 16 |
About Grégor Andelfinger
Grégor Andelfinger is a scholar working on Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health, Epidemiology, Molecular Biology and Genetics, having authored 96 papers that have together received 3.2k indexed citations. Recurring topics across this work include Congenital Heart Disease Studies (23 papers), Congenital heart defects research (23 papers), Chemotherapy-induced cardiotoxicity and mitigation (15 papers), Childhood Cancer Survivors' Quality of Life (12 papers), Cardiac Valve Diseases and Treatments (10 papers), Aortic Disease and Treatment Approaches (8 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Protein Tyrosine Phosphatases (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.4k citations), Pulmonary and Respiratory Medicine (901 citations), Epidemiology (880 citations), Molecular Biology (1.5k citations) and Pediatrics, Perinatology and Child Health (319 citations). Grégor Andelfinger has collaborated with scholars based in Canada, United States and France. Frequent co-authors include D. Woodrow Benson, Kerry A. Shooner, Lisa J. Martin, Linda Cripe, Mona Nemer, Brigitte Laforest, Alfred L. George, Patrick van Vliet, Michel Pucéat and Séverine Leclerc. Their work appears in journals such as Canadian Journal of Cardiology, Journal of Pediatric Hematology/Oncology, PLoS Genetics, The American Journal of Human Genetics and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.